Study to Determine the Concentrations of Maraviroc in Semen, the Seminal to Plasma Ratio of Maraviroc and the Variability in Seminal to Plasma Ratios Over the Maraviroc Dosing Period.

Trial Profile

Study to Determine the Concentrations of Maraviroc in Semen, the Seminal to Plasma Ratio of Maraviroc and the Variability in Seminal to Plasma Ratios Over the Maraviroc Dosing Period.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2014

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jun 2012 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 04 Jun 2012 Planned end date changed from 1 Jul 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov record.
    • 09 Dec 2009 Planned end date (1 Jul 2010) added as reported by ClinicalTrials.gov record (NCT01009034).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top